BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15235906)

  • 1. Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.
    Onda M; Emi M; Nagai H; Nagahata T; Tsumagari K; Fujimoto T; Akiyama F; Sakamoto G; Makita M; Kasumi F; Miki Y; Tanaka T; Tsunoda T; Nakamura Y
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):537-45. PubMed ID: 15235906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic prognostic index influences patient outcome for node-positive breast cancer.
    Asaka S; Fujimoto T; Akaishi J; Ogawa K; Onda M
    Surg Today; 2006; 36(9):793-801. PubMed ID: 16937283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.
    Nagahata T; Onda M; Emi M; Nagai H; Tsumagari K; Fujimoto T; Hirano A; Sato T; Nishikawa K; Akiyama F; Sakamoto G; Kasumi F; Miki Y; Tanaka T; Tsunoda T
    Cancer Sci; 2004 Mar; 95(3):218-25. PubMed ID: 15016320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes.
    Tsumagari K; Chijiiwa K; Nagai H; Makita M; Kasumi F; Akiyama F; Sakamoto G; Miki Y
    Breast Cancer; 2005; 12(3):166-77. PubMed ID: 16110286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.
    Jiang D; Zhao N
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):579-87. PubMed ID: 16761122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
    Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
    Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
    Langerød A; Zhao H; Borgan Ø; Nesland JM; Bukholm IR; Ikdahl T; Kåresen R; Børresen-Dale AL; Jeffrey SS
    Breast Cancer Res; 2007; 9(3):R30. PubMed ID: 17504517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer.
    Patani N; Jiang W; Mokbel K
    Int J Cancer; 2008 Jun; 122(11):2646. PubMed ID: 18302153
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved breast cancer prognosis through the combination of clinical and genetic markers.
    Sun Y; Goodison S; Li J; Liu L; Farmerie W
    Bioinformatics; 2007 Jan; 23(1):30-7. PubMed ID: 17130137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.
    Cimino D; Fuso L; Sfiligoi C; Biglia N; Ponzone R; Maggiorotto F; Russo G; Cicatiello L; Weisz A; Taverna D; Sismondi P; De Bortoli M
    Int J Cancer; 2008 Sep; 123(6):1327-38. PubMed ID: 18561318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
    Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
    J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
    Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adélaïde J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D
    Int J Cancer; 2003 Dec; 107(5):854-62. PubMed ID: 14566838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.